GQG Partners’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.6M Sell
209,268
-1,247,762
-86% -$87.2M 0.02% 64
2025
Q1
$107M Sell
1,457,030
-2,918,310
-67% -$214M 0.17% 50
2024
Q4
$287M Sell
4,375,340
-1,099,802
-20% -$72.1M 0.43% 45
2024
Q3
$427M Buy
5,475,142
+2,475,558
+83% +$193M 0.67% 39
2024
Q2
$234M Buy
2,999,584
+2,780,090
+1,267% +$217M 0.35% 35
2024
Q1
$14.9M Sell
219,494
-13,638,889
-98% -$924M 0.02% 46
2023
Q4
$933M Sell
13,858,383
-187,489
-1% -$12.6M 1.98% 18
2023
Q3
$951M Sell
14,045,872
-7,152,626
-34% -$484M 2.2% 17
2023
Q2
$1.52B Sell
21,198,498
-346,889
-2% -$24.8M 3.49% 10
2023
Q1
$1.5B Buy
21,545,387
+4,348,916
+25% +$302M 3.91% 8
2022
Q4
$1.17B Sell
17,196,471
-1,181,260
-6% -$80.1M 3.15% 12
2022
Q3
$1.01B Sell
18,377,731
-337,929
-2% -$18.5M 2.91% 16
2022
Q2
$1.24B Buy
18,715,660
+434,979
+2% +$28.8M 3.04% 11
2022
Q1
$1.21B Sell
18,280,681
-1,173,071
-6% -$77.8M 2.81% 12
2021
Q4
$1.13B Buy
19,453,752
+973,398
+5% +$56.7M 2.81% 14
2021
Q3
$1.11B Buy
18,480,354
+1,848,321
+11% +$111M 3.04% 13
2021
Q2
$996M Buy
16,632,033
+1,220,580
+8% +$73.1M 2.93% 15
2021
Q1
$766M Buy
15,411,453
+41,054
+0.3% +$2.04M 2.8% 15
2020
Q4
$768M Buy
15,370,399
+4,616,470
+43% +$231M 2.63% 15
2020
Q3
$589M Buy
10,753,929
+1,567,375
+17% +$85.9M 2.02% 18
2020
Q2
$486M Buy
9,186,554
+1,249,163
+16% +$66.1M 2.14% 15
2020
Q1
$355M Buy
7,937,391
+937,164
+13% +$41.9M 2.44% 13
2019
Q4
$349M Buy
7,000,227
+1,071,004
+18% +$53.4M 2.41% 15
2019
Q3
$264M Buy
5,929,223
+846,530
+17% +$37.7M 2.69% 15
2019
Q2
$210M Sell
5,082,693
-72,576
-1% -$2.99M 2.26% 16
2019
Q1
$208M Buy
5,155,269
+2,157,252
+72% +$87M 2.58% 17
2018
Q4
$114M Buy
2,998,017
+309,229
+12% +$11.8M 1.76% 20
2018
Q3
$106M Buy
+2,688,788
New +$106M 1.73% 21